Activity of dasatinib against L576P KIT mutant melanoma: molecular, cellular, and clinical correlates
达沙替尼对L576P KIT突变型黑色素瘤的活性:分子、细胞和临床相关性
期刊:Molecular Cancer Therapeutics
影响因子:5.5
doi:10.1158/1535-7163.MCT-09-0459
Woodman, Scott E; Trent, Jonathan C; Stemke-Hale, Katherine; Lazar, Alexander J; Pricl, Sabrina; Pavan, Giovanni M; Fermeglia, Maurizio; Gopal, Y N Vashisht; Yang, Dan; Podoloff, Donald A; Ivan, Doina; Kim, Kevin B; Papadopoulos, Nicholas; Hwu, Patrick; Mills, Gordon B; Davies, Michael A